JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicolini, U.
Right arrow Articles by Scaperrotta, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicolini, U.
Right arrow Articles by Scaperrotta, R. C.

Journal of Ultrasound in Medicine, Vol 4, Issue 7 347-351, Copyright © 1985 by American Institute of Ultrasound in Medicine


JOURNAL ARTICLE

The contribution of sonographic evaluation of ovarian size in patients with polycystic ovarian disease

U. Nicolini, E. Ferrazzi, M. Bellotti, P. Travaglini, R. Elli and R. C. Scaperrotta

The ovarian size of 44 patients with clinical and endocrinologic findings suggesting polycystic ovarian disease (PCOD) was studied by ultrasound examination. Reproducibility of the ovarian parameters (transverse, longitudinal, and anteroposterior diameters, and volume) was also evaluated. The endocrine status of each patient was evaluated by assay of blood levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, 17 beta-estradiol (17 beta E2), and serum prolactin (PRL). Ovarian size was also investigated in 40 women with normal cycles, following the same ultrasound procedure. The mean ovarian volume of the normal controls was statistically different from the mean of patients with PCOD. Only 34 per cent of the patients affected by PCOD were above the second standard deviation of normal ovarian size. A correlation between endocrinologic findings and ovarian size was observed in women whose ovarian size fell within normal limits; these women had higher, though not statistically different, values of LH and testosterone and lower values of 17 beta E2 and PRL compared with patients with enlarged ovaries. Responsiveness to treatment was more easily observed in patients with ovarian enlargement.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Legro, P. Chiu, A. R. Kunselman, C. M. Bentley, W. C. Dodson, and A. Dunaif
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2571 - 2579.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
K Lakhani, A M Seifalian, W U Atiomo, and P Hardiman
Polycystic ovaries
Br. J. Radiol., January 1, 2002; 75(889): 9 - 16.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Institute of Ultrasound in Medicine.